Autism Therapeutics Company Management

Dr. Paul Herscu :: CEO

Prior to becoming a founding partner and CEO of Autism Therapeutics, Dr. Herscu co-founded Personalized Pharmaceutical Systems LLC (“PPS”), a Massachusetts based clinical trial enrichment technology company. PPS has worked with leading pharmaceutical companies to identify novel treatment response-related subpopulations and clinical trial enrichment solutions in Angioedema, Sepsis, ADHD, and Rett Syndrome. Since 2008, Dr. Herscu has served as a scientific advisor to a privately held plasma fractionation and biologic drug development company with multiple products in late stage clinical trials for severe inflammatory conditions.

Since 1986, Dr. Herscu has been a clinician specializing in the treatment of Autism Spectrum Disorders, ADHD, and various genetic and chromosomal abnormalities in children for which he is considered a worldwide thought leader in complimentary alternative medicine (CAM) treatment and clinical trial design.

Dr. Herscu is a published author in peer reviewed journals in the development of Clinical Prediction Guides (CPGs) and their potential to increase success in Phase II-IV clinical trials, novel therapies for sepsis, the treatment of angioedema, and methodologies to increase rigor in CAM clinical trials. He is also an inventor on a patent relating to novel pharmaceutical treatments for ADHD and ASD.

Dr. Herscu holds a Doctorate from the National College of Naturopathic Medicine, Portland, Oregon, and Masters in Public Health is from University of Massachusetts (UMASS).